4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0001415889-25-017627
Options or other derivatives
- Director acquired 20,275 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| RA CAPITAL MANAGEMENT, L.P. Director | 2025-06-13 | Grant or award · Stock Option (Right to Buy) | +20,275 | 20,275 | I | ||
Loading xslF345X05/form4-06182025_120627.xml…